Skin cancer screening by dermatologists, family practitioners, and internists: Barriers and facilitating factors

Archives of Dermatology

Volumn 147, Issue 1, 2011, Pages 39-44

  Oliveria, Susan A ^a   Heneghan, Maureen K ^a   Cushman, Linda F ^b   Ughetta, Eloise A ^a   Halpern, Allan C ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b Columbia University ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER SCREENING; COMORBIDITY; DERMATOLOGIST; GENERAL PRACTITIONER; HUMAN; INTERNIST; MAJOR CLINICAL STUDY; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; PROFESSIONAL PRACTICE; RANDOMIZED CONTROLLED TRIAL; SKIN CANCER; SKIN EXAMINATION; SPECIALIZATION; STATISTICAL ANALYSIS;

ADULT; AGED; ATTITUDE TO HEALTH; DATA COLLECTION; DERMATOLOGY; EARLY DETECTION OF CANCER; EMOTIONS; FAMILY PRACTICE; FEMALE; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; NEVUS; PHYSICIAN'S PRACTICE PATTERNS; PRIMARY HEALTH CARE; RISK FACTORS; SKIN NEOPLASMS; TIME FACTORS; UNITED STATES;

EID: 78751552544     PISSN: 0003987X     EISSN: 15383652     Source Type: Journal    
DOI: 10.1001/archdermatol.2010.414     Document Type: Article

References (40)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics, 2009. CA Cancer J Clin. 2009;59(4):225-249.
2. Carey WP Jr, Thompson CJ, Synnestvedt M, et al. Dysplastic nevi as a melanoma risk factor in patients with familial melanoma. Cancer. 1994;74(12):3118-3125. (Pubitemid 24375068)
3. MacKie RM, McHenry P, Hole D. Accelerated detection with prospective surveillance for cutaneous malignant melanoma in high-risk groups. Lancet. 1993;341(8861):1618-1620. (Pubitemid 23175245)
4. Masri GD, Clark WH Jr, Guerry D IV, Halpern A, Thompson CJ, Elder DE. Screening and surveillance of patients at high risk for malignant melanoma result in detection of earlier disease. J Am Acad Dermatol. 1990;22(6, pt 1):1042-1048. (Pubitemid 20186126)
5. Titus-Ernstoff L, Ernstoff MS, Kirkwood JM, Barnhill RL, Fine J, Duray PH. Usefulness of frequent skin examination for the early detection of second primary cutaneous melanoma. Cancer Detect Prev. 1989;13(5-6):317-321.
6. Vasen HF, Bergman W, van Haeringen A, Scheffer E, van Slooten EA. The familial dysplastic nevus syndrome: natural history and the impact of screening on prognosis: a study of nine families in the Netherlands. Eur J Cancer Clin Oncol. 1989;25(2):337-341. (Pubitemid 19054838)
7. Losina E, Walensky RP, Geller A, et al. Visual screening for malignant melanoma: a cost-effectiveness analysis. Arch Dermatol. 2007;143(1):21-28.
8. Schneider JS, Moore DH II, Mendelsohn ML. Screening program reduced melanoma mortality at the Lawrence Livermore National Laboratory, 1984 to 1996. J Am Acad Dermatol. 2008;58(5):741-749.
9. American Cancer Society. Guidelines for the Cancer-Related Checkup: An Update. Atlanta, GA: American Cancer Society; 1993.
10. Canadian Task Force on the Periodic Health Examination. Canadian Guide to Clinical Preventive Health Care. Ottawa, ON: Canada Communication Group; 1994:850-861.
11. Goldsmith LA, Koh HK, Bewerse BA, et al. Full proceedings from the National Conference to Develop a National Skin Cancer Agenda: American Academy of Dermatology and Centers for Disease Control and Prevention, Washington, DC, April 8-10, 1995. J Am Acad Dermatol. 1996;35(5, pt 1):748-756.
12. NIH Consensus Development Conference Statement on Diagnosis and Treatment of Early Melanoma, January 27-29, 1992. Consens Statement. 1992;10(1):1-25.
13. Friedman RJ, Rigel DS, Silverman MK, Kopf AW, Vossaert KA. Malignant melanoma in the 1990s: the continued importance of early detection and the role of physician examination and self-examination of the skin. CA Cancer J Clin. 1991;41(4):201-226.
14. Koh HK, Lew RA, Prout MN. Screening for melanoma/skin cancer: theoretic and practical considerations. J Am Acad Dermatol. 1989;20(2, pt 1):159-172.
15. Wolff T, Tai E,Miller T. Screening for skin cancer: an update of the evidence for the US Preventive Services Task Force. Ann Intern Med. 2009;150(3):194-198.
16. US Preventive Services Task Force. Screening for skin cancer: US Preventive Services Task Force recommendation statement. Ann Intern Med. 2009;150(3):188-193.
17. Federman DG, Kravetz JD, Kirsner RS. Skin cancer screening by dermatologists: prevalence and barriers. J Am Acad Dermatol. 2002;46(5):710-714.
18. Kirsner RS, Muhkerjee S, Federman DG. Skin cancer screening in primary care: prevalence and barriers. J Am Acad Dermatol. 1999;41(4):564-566.
19. Oliveria SA, Christos PJ, Marghoob AA, Halpern AC. Skin cancer screening and prevention in the primary care setting: national ambulatory medical care survey 1997. J Gen Intern Med. 2001;16(5):297-301.
20. Oliveria SA, Altman JF, Christos PJ, Halpern AC. Use of nonphysician health care providers for skin cancer screening in the primary care setting. Prev Med. 2002;34(3):374-379.
21. McDonald CJ. American Cancer Society perspective on the American College of Preventive Medicine's policy statements on skin cancer prevention and screening. CA Cancer J Clin. 1998;48(4):229-231.
22. Shenefelt PD. Skin cancer prevention and screening. Prim Care. 1992;19(3):557-574.
23. Wender RC. Barriers to effective skin cancer detection. Cancer. 1995;75(2)(suppl):691-698.
24. Williams PA, Williams M. Barriers and incentives for primary-care physicians in cancer prevention and detection. Cancer. 1987;60(8)(suppl):1970- 1978.
25. Medical Marketing Service, Inc. Medical Marketing Service Web site. Wood Dale, IL: 2005. http://www.mmslists.com/. Accessed August 2006. .
26. Dolan NC, Martin GJ, Robinson JK, Rademaker AW. Skin cancer control practices among physicians in a university general medicine practice. J Gen Intern Med. 1995;10(9):515-519.
27. Federman DG, Concato J, Caralis PV, Hunkele GE, Kirsner RS. Screening for skin cancer in primary care settings. Arch Dermatol. 1997;133(11):1423-1425.
28. Geller AC, O'Riordan DL, Oliveria SA, Valvo S, Teich M, Halpern AC. Overcoming obstacles to skin cancer examinations and prevention counseling for high-risk patients: results of a national survey of primary care physicians. J Am Board Fam Pract. 2004;17(6):416-423.
29. Geller AC, Koh HK, Miller DR, Clapp RW, Mercer MB, Lew RA. Use of health services before the diagnosis of melanoma: implications for early detection and screening. J Gen Intern Med. 1992;7(2):154-157.
30. Woodwell DA, Cherry DK. National Ambulatory Medical Care Survey: 2002 summary. Adv Data. 2004;(346):1-44.
31. Lewis CE. Disease prevention and health promotion practices of primary care physicians in the United States. Am J Prev Med. 1988;4(4)(suppl):9-16.
32. Federman DG, Kravetz JD, Haskell SG, Ma F, Kirsner RS. Full-body skin examinations and the female veteran: prevalence and perspective. Arch Dermatol. 2006;142(3):312-316.
33. Balch CM, Soong SJ, Shaw HM, et al. An analysis of prognostic factors in 8500 patients with cutaneous melanoma. In: Balch CM, Houghton AN, Milton AN, Sober AJ, Soong SJ, eds. Cutaneous Melanoma. Philadelphia, PA: JB Lippincott; 1992:165-187.
34. Brady MS, Oliveria SA, Christos PJ, et al. Patterns of detection in patients with cutaneous melanoma. Cancer. 2000;89(2):342-347.
35. Breslow A. Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma. Ann Surg. 1970;172(5):902-908.
36. Epstein DS, Lange JR, Gruber SB, Mofid M, Koch SE. Is physician detection associated with thinner melanomas? JAMA. 1999;281(7):640-643.
37. Clark WH Jr, Elder DE, Guerry D IV, et al. Model predicting survival in stage I melanoma based on tumor progression. J Natl Cancer Inst. 1989;81(24):1893-1904.
38. Ferrone CR, Ben Porat L, Panageas KS, et al. Clinicopathological features of and risk factors for multiple primary melanomas. JAMA. 2005;294(13):1647- 1654.
39. Halpern AC, Guerry D IV, Elder DE, et al. Dysplastic nevi as risk markers of sporadic (nonfamilial) melanoma: a case-control study. Arch Dermatol. 1991;127(7):995-999.
40. Kirsner RS, Federman DG. The rationale for skin cancer screening and prevention. Am J Manag Care. 1998;4(9):1279-1284.